Simone Biles Partnered with Arcutis for Skin Campaign

The gymnast has launched an awareness initiative regarding chronic inflammatory skin conditions like eczema.

Updated on Sept. 29, 2026 in Beauty

Bold vector editorial illustration featuring a stylized geometric skin cell form in teal and coral, representing dermatological awareness. — Olympic gymnast Simone Biles has partnered with Arcutis Biotherapeutics to launch a national campaign raising awareness for chronic inflammatory skin conditions. AI Illustration. Upload story photo >

Live Poll

Do you trust celebrity-led awareness campaigns for prescription medications?

Olympic gymnast Simone Biles has partnered with Arcutis Biotherapeutics to lead a national campaign focused on chronic skin conditions. The initiative aims to reduce stigma and encourage Americans to seek steroid-free treatment options for issues like seborrheic dermatitis.

Why it matters

The campaign targets the estimated 36 million Americans living with inflammatory skin conditions to help them find effective, long-term management. By highlighting her personal journey, Biles advocates for patients to consult healthcare providers about specialized therapy.

Approximately 36 million Americans live with inflammatory skin conditions. ZORYVE is currently the top-prescribed branded topical therapy for three distinct inflammatory skin conditions combined.

The players

Simone Biles

She is an Olympic gymnast and an advocate for health awareness who manages her own chronic skin conditions.

Arcutis Biotherapeutics

This is a biopharmaceutical company based in Westlake Village, California, that specializes in dermatological treatments.

The details

Biles utilizes ZORYVE, a once-daily, steroid-free PDE4 inhibitor, to manage her personal symptoms of eczema and seborrheic dermatitis. The campaign urges individuals to prioritize doctor-led treatment plans to achieve clearer skin and better symptom control.

September 29, 2026: Arcutis Biotherapeutics announced the partnership with Simone Biles.
June 2025: The American Academy of Dermatology issued updated treatment recommendations for ZORYVE.
2024: ZORYVE cream received the Glamour Beauty and Wellness Award.

Gymnastics
Sept. 23
Jordan Chiles Announced 2028 Olympic Bid
Allergies
Sept. 22
Experts Released Alopecia Areata Treatment Guidelines
Football
Sept. 29
Kim Disclosed ADHD Diagnosis as Garrett Faced Surgery

Culture Shift

The involvement of high-profile athletes in medical advocacy signals a shift toward celebrity-driven education for chronic health conditions. This trend mirrors a broader societal push to destigmatize dermatological ailments that affect millions of daily lives.

Patients may find it easier to initiate conversations with their dermatologists about steroid-free treatment options after seeing the campaign. Individuals should verify with their insurance providers if these specific topical therapies are covered under their current health plans.

The takeaway

Chronic skin issues often require a long-term approach rather than temporary fixes. Consulting a healthcare provider remains the most effective way to determine if a steroid-free PDE4 inhibitor fits your specific health profile.